News

Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release

Biotech gets back on track in November December 01, 2009 | Press Release

Biotech takes it on the chin in October November 02, 2009 | Press Release

  See all News
 
Sign up to receive email notifications about our upcoming events and news.


Private Equity

Burrill Private Equity Group’s active management creates value in investments through a structured and rigorous strategy which includes:

  • Select (using our domain expertise and large proprietary deal flow) undervalued companies in which we can acquire significant influential stakes
  • Acquire significant equity positions (often through PIPEs)
  • Solidify investee’s financial position— removing financial instability
  • Rationalize and/or accelerate pipeline development
  • Create partnerships with major Pharma or other industry players
  • Mentor management and take Board leadership position (augment Board)
  • Institute appropriate financial controls
  • Optimize opportunities for future equity financing, acquisitions, and divestitures.